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Abstract
Background: Studies exploring parents’ trial experiences generally relate to their understanding of the consent
process and the development of researcher strategies to facilitate recruitment and retention. The aim was to better
understand parents’ experience of being part of a trial at the time and their perceptions of trial participation
in retrospect.
Methods: Data were collected in a number of ways: from recorded discussions between parents and clinicians about
the MRI or ultrasound, in open-text responses to questionnaires and in qualitative interviews at 1 and 2 years after
participation. Thematic analysis was undertaken using NVivo10.
Results: Key themes identified were ‘deciding to take part’, with subthemes associated with ‘benefitting self’,
‘benefitting others’ and ‘being prepared’; ‘the randomisation process’ with subthemes relating to ‘acceptance’
and ‘understanding’ and ‘actual engagement’ with subthemes of ‘practicalities’ and ‘care from responsive staff’.
Conclusion: Parents’ perspectives on the trial and the processes and information received reflect their
understanding and experience of the trial and the value of parent-friendly information-giving about participation,
randomisation and follow-up. The practical and logistical points raised confirm the key issues and parents’ need for
sensitive care and support in the course of a trial. Looking back, almost all parents were positive about their experience
and felt that the family had benefitted from participation in the trial and follow-up studies, even when the
developmental outcomes were poor.
Trial registration: ClinicalTrials.gov, ID: NCT01049594. https://clinicaltrials.gov/ct2/show/NCT01049594.
Registered on 13 January 2010.
EudraCT: EudraCT: 2009-011602-42. https://www.clinicaltrialsregister.eu/.
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Background
The complexity of studies involving children and the
need for proxy consent, usually given by the parents,
provides a unique set of circumstances in which to ex-
plore perceptions of research and trial participation [1].
Parents seem to welcome being asked if their child could
participate in a study even if, for whatever reason, they
decide to decline [1, 2]. There are studies which specific-
ally investigated parental motivates to consenting their
baby or child to taking part in a study. The most com-
mon explanations are personal benefit for the child or
family and altruistic reasons [3–5]. Researchers have also
looked at the views of parents on specific aspects of
trials; for example, deferred consent in neonatal and
paediatric clinical trials with treatment that was con-
sidered emergency, using both quantitative and quali-
tative methods [6–8].
Studies exploring parents’ experiences and perceptions
of their child being part of a research study generally re-
late to their recollection and understanding of the con-
sent process [9–12], the exploration and development of
strategies to facilitate recruitment and retention [1] and
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waiving consent in a trial [13]. Evidence, based on inter-
views or focus groups suggests that the information that
parents value most when deciding about their child’s
participation in research is practical information about
what will be involved and when this will take place [4].
Other factors influencing parental decision-making in-
clude their own knowledge and experience, their child’s
health status, staff attitudes to research and the way that
staff communicate with them [3].
Although some studies have investigated parents’
longer-term perspectives on their child being part of a
trial [4], these are few in number. The present study was
part of a programme of work that involved a clinical
trial, with qualitative components that focussed on paren-
tal perceptions and experience over the whole course of
their participation in the planned research programme
through to outcomes for their children at 2 years [14].
The aim was better to understand parents’ experience at
the time, in close proximity to the intervention and their
perceptions of trial participation in the longer term.
Methods
The ePrime study, involved a trial of information-giving
to parents following cerebral magnetic resonance im-
aging (MRI) and ultrasound (US) scans undertaken at
term of babies who had been born before 33 weeks’
gestation. We carried out a parallel-group randomised
controlled trial with 1:1 allocation that compared the ef-
fect of prognostic information derived from either MRI
or ultrasound on parental anxiety and coping, health
costs, and health-related quality of life; and in a nested
diagnostic evaluation with blinded assessment compared
the precision of the two types of scan. Thus, in the ran-
domised controlled trial (RCT) we tested whether infor-
mation from MRI improved infant care and family
wellbeing compared to information from cerebral ultra-
sound. Parents received either the MRI or ultrasound
scan result and prognostic information based upon that
particular scan. Families were subsequently followed up
and a full developmental assessment of the child was
carried out at 20–24 months’ corrected age.
Babies were recruited to the ePrime study while being
cared for in one of 13 neonatal units in the London area.
Written informed consent from parents was obtained
at the recruitment site and affirmed at the scanning ap-
pointment at the specialist centre. Data measuring and
exploring the impact on parents’ of the scan result were
collected over 2 years and the data presented in this
secondary analysis were drawn from three study
components:
1. Audio-recordings were made at the time of
discussions between parents and clinicians about the
baby’s MRI or ultrasound result with parental
agreement and consent. These discussions took
place immediately following the scan at term.
The recordings were fully transcribed and analysed
thematically using NVivo10 [15]. While the audio-
recordings of the clinician-parent discussions were
primarily undertaken to capture the ways in which
medical staff gave information based on the baby’s
scan findings and prognosis [16, 17] the discussion
also involved parents’ reactions to allocation and
more generally to participation in the trial. The
recordings were made on a subset of 60 clinician-
parent discussions targeting three time periods
during the first, second and third years of the study,
carried out consecutively. Analysis was based on
transcripts of 36 of these interviews, saturation
having been reached
2. Parent-completed questionnaires, containing
standard measures and general questions giving
them the opportunity to respond in their own
words, were sent to all parents following the term
scanning appointment. The questionnaires were
administered at three time points: shortly after the
term scan visit, 1 year post scan and immediately
prior to the developmental assessment carried out
2 years after the scan
3. Qualitative interviews with subsamples of parents
were carried out by telephone around the time of
their child’s first birthday and when their child had
reached approximately 2 years’ corrected age. Those
parents who had previously consented to interview
were invited to reaffirm their consent by the
research nurse when contacted. Initially, parents
were randomly selected; however, towards the end
of data collection purposive sampling was used to
ensure diversity of this sample in terms of age,
education and ethnicity. A topic guide was used by
the interviewer, which included references to the
trial and scanning appointment day. Efforts were
made to interview both mothers and fathers. No
attempt was made to interview the same parents at
1 and 2 years. The interviews were recorded and
fully transcribed
Transcriptions of the parent-clinician discussions,
open-text responses in the questionnaires and transcrip-
tions of the 1- and 2-year interviews were analysed the-
matically with a focus on study participation using
NVivo10 [15]. It became apparent in the course of ana-
lysis, when examining data from individual study com-
ponents, that there were commonalities in terms of the
themes relating to participation in the trial. Thus, these
qualitative data were pooled and analysed thematically
in this secondary analysis [18]. Extracts of the data
relating to trial participation were coded and the codes
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were organised into themes and subthemes. New codes
were generated when the data appeared to capture
something different. The coding framework was then
reviewed and revised until the final structure was agreed
by MR and MH, leading to the identification of key
themes.
Results
A total of 434 families with 510 babies were recruited
and participated in the trial, of which 210 were in the
MRI arm and 214 in the US arm of the trial, 36.2% of
those eligible [14]. All the babies were born before
33 weeks’ gestation (mean gestational age of 30 weeks
and a mean birth weight of 1305 g.)
Audio-recordings of clinician-parent interviews at
around term involving 34 mothers, 17 fathers and 1
grandmother, related to 43 babies (including five sets of
twins and one set of triplets) were analysed. Most
families (80% of the 434 participating in the main study),
agreed to participate in the audio-recorded discussions.
A total of 60 recordings were made and a subset of 36 of
these carried out by different clinicians, evenly distributed
over the three different years of the study, were analysed.
The discussions reflected information-giving and parent’s
understanding and perceptions of the trial.
In the 434 families more mothers than fathers com-
pleted the questionnaires: 84% of mothers and 79% of
fathers, shortly after the scans were carried out; 82%
and 62%, respectively, at 1 year and 97% and 82%, re-
spectively, at 2 years. Of the parents who completed
questionnaires, over 94% responded to an open-text
question in one or more of the questionnaires.
At 1 year, 30 parents (25 mothers, 5 fathers) were
interviewed by telephone. The interviews related to 35
babies (including four sets of twins and one set of trip-
lets). During these interviews parents talked about why
they had agreed to take part in the study and recalled
the scanning visit. This led to discussion about their per-
ceptions of the study and the way in which it was
conducted.
At 2 years, 30 parents (21 mothers, 9 fathers) were
interviewed by telephone several weeks after the 20–24
months’ corrected age developmental assessment. The
interviews related to 31 babies (including four sets of
twins). During these interviews, parents recalled the recent
developmental assessment and the discussion led them to
reflect upon the totality of their ‘ePrime experience,’ and
their reasons for taking part in the study. None of the
parents who took part in the 2-year interview had partici-
pated in the 1-year interview.
This secondary analysis led to the identification of
three key themes about experience of the trial, which in-
clude a number of subthemes (Table 1).
Evidence for all of the trial-related themes and sub-
themes arose from two or more of the data sources.
The themes and subthemes are described with direct
quotes used for illustration. Details associated with the
quotations are as follows: ‘M’ denotes mother, ‘F’, father
and ‘C’ clinician; ‘AR’ indicates audio-recording; ‘Q2’,
‘Q3’, and ‘Q4’indicates the questionnaire completed
after the scan and at 1 and 2 years; the year-1 and year-
2 interviews are indicated as ‘Y1 Int’ and ‘Y2 Int’,
respectively.
Deciding to take part
This key theme which describes the feelings and self-
ascribed motivation of parents who took part in the trial.
Three subthemes were identified. The first two relate to
the rationale that parents put forward for consenting to
their child’s participation in the study. Reciprocity was a
construct underlying this theme and is reflected from
two perspectives: parents framed their reasons in terms
of ‘benefitting others’ and ‘benefitting self ’ (the baby,
Table 1 Key themes and subthemes relating to participation in
trial and follow-up
Key themes Subthemes
Deciding to take part Benefitting others:
• Giving something back
• Helping other babies and families
• Improving the provision of care
Benefitting self, baby and family:
• Feeling valued
• Access to information and knowledge
• Hoping for magnetic resonance
imaging (MRI) result
• Support from research team
• Prompt and early diagnosis
Being prepared:
• Thinking through what is involved and
what might happen
• Inadequate information about the study
The randomisation process Accepting the process:
• What we would have liked
Understanding randomisation:
• An equal chance
• Only one result
Actual engagement Practicalities:
• The way the study was conducted
• Impact on parents
Care from responsive staff:
• Being looked after
• Needs recognised
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themselves and the wider family). The third subtheme
which arose in the context of deciding to take part was
‘being prepared’ which concerns their reflections on
their own level of understanding at the time of making
the decision to participate.
Benefitting others
Parents were explicit about valuing what they had re-
ceived in terms of health care, particularly the neonatal
care that their baby had received. They gave altruistic
reasons in principle for agreeing to involvement in the
study: they wished to help other babies and families and
referred to wanting to ‘give something back, after all the
help that you get during the process of having a prema-
ture baby’. However, they were less specific about how
this might work. Nevertheless, all parents were pleased
to ‘be part of it [the study]’, grateful for the care their
family had received and felt their involvement in the
research had the potential to ‘help other people as well’
and improve the delivery of neonatal care in the fu-
ture. At the same time they emphasised the smallness
of their role and acknowledged the incremental way in
which it might help. The references to giving back
continued over the 2-year period that followed
recruitment:
M: ‘Oh we want to do it anyway, because they were so
good.’
C: ‘Well, thank you, thank you for that. We’re very
grateful, for that.’
M: ‘If it helps others…’
F: ‘I mean, I was a bit dubious about doing it, wasn’t
I? But you know, they were really good in X
[hospital]. Well you know, if a tiny percent helps
anyone else.’
M: ‘Exactly.’AR 305
‘I’ve always thought it was a good idea for the
girls to get involved in stuff like this, you know,
studies and that. So the one thing that’s been
stuck in my mind is that this is their time to help.’
Y1 Int M1266-1279
‘I think we were in that situation where we felt
it would be very easy just to say “no” and let’s
just not do it. But at some point, you know, if
things are to improve, someone has to say,
“let’s do this”. We decided that this had happened
to us and actually someone might benefit down
the line, if we actually do something.’
Y1 Int M3239
‘I’m glad to be part of the research programme – if
not for me – to help others.’ Q2 M3095
‘I think, you know, it’s, err, nice to feel that we can
contribute in a very small way, but just towards, you
know,…the amazing things that can be done for
premature babies now.’ Y2 Int M1776-1769
Benefitting self – should be benefitting self, baby and
family
Most parents gave altruistic reasons for taking part in
the research in principle; they specifically referred to the
potential benefits to their baby, themselves and their
wider family. They particularly felt that the opportunity
for this more detailed scan could provide them with
knowledge and additional information about their baby’s
prognosis:
‘Well it’s great to be able to be part of something like
this because either way you get to go away with more
information… And you can move forward that way.’
AR M1636
‘Simply I think one of the main reasons, the first main
reason is the fact that it gave us the opportunity of
possibly finding out a bit more about the situation.’
Y1 Int F1130
Although not directly asked, most parents commented
that they hoped to be given the MRI findings at the
scanning appointment and the possibility of that and the
resulting information was a potential gain. This was
recognised in close proximity to the scanning and also
reflected on over a longer time period:
C: ‘The results you’re going to get are of the MRI.’
M: ‘Oh, fantastic.’
F: ‘Great.’
M: ‘I think we were hoping for that actually, yea.’
AR 1266-1279
‘I think the possibility of getting the MRI helped us to
decide.’ Yr1 Int M3239
‘We did it hoping to get the MRI result.’ Yr 2 F4845
Similarly, parents agreed to take part in the study be-
cause of the developmental assessment which could
provide further information about their child’s progress
and further prognosis. They were explicit about the on-
going contact provided by the research team during the
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study being another reason why they agreed to partici-
pate. At the same time parents could feel valued at be-
ing asked to take part in the study and some alluded to
their own feelings of self-worth in deciding to
participate:
‘I think I took part because you don’t know when you
have a premature baby. You don’t know what’s wrong
with them. You’re never going to find out, you know,
I mean obviously they give you information why this
or why that, in my circumstance it was myself that
was ill and that caused 2583 to come 3 months early.
But other people, babies just don’t grow and they have
to come out. So I think the benefit of it and knowing,
you know, this is good. You know, you have your
babies normally at full term and you go home within
3, 4 hours. But here I was thinking, well 2583 was in
hospital a long time. So it’s nice to know and also to
be quite honest, nice to have the support there after
he was brought home. You know, they ring me and
we have a chat, he got his first little birthday card
from them. For me that’s something that I want to
keep for him when he grows up.’ Yr 1 Int M2583
‘I do remember that was another reason why we were
happy to take part in this study, because we will be
coming in with the children when they’re 2 years old
and they’ll be assessed and it will be really good for us
to know where they’re up to when they’re at that age.’
Yr 1 Int M2047-2059
‘I think, you know, for us one of the reasons why we
decided to be part of the ePrime study was because,
you know, it wasn’t just…, it wasn’t so much to do
with the actual brain structure or anything like
that, it was all to do with her developmental needs.’
Yr 2 Int M4063
‘It was wonderful to be part of it, we’re just glad we
were asked and that we could be part of it.’
Yr 2 Int F1910
Being prepared
Within this subtheme parents talked about whether or
not they had been adequately prepared for what the
scanning actually involved and the results that they
might receive in participating in the trial. For some, it
was only in retrospect that they realised that they had
been poorly prepared. This was either because of their
own lack of understanding about the study require-
ments, not thinking through what the study could in-
volve emotionally or practically, or the implications
for them of their child’s participation. Insufficient
explanations or limited information from the research
team about the scans was also felt to have contributed:
‘I found it very difficult returning to the neonatal unit
for the MRI scan etc.’ Q2 M3262
‘The sedation, I don’t think that had properly been
explained because they had to give it in a certain way,
it was oral sedation and that was quite distressing.’
Yr 1 Int M3088
‘I was a bit concerned about her having the MRI when
we actually got there and saw the room and saw the
machine. She just seemed so little.’ Yr 1 Int M2345
‘I just remember being there, I just remember that it
was intense and it felt slightly intimidating because it
seemed so dramatic.’ Yr 2 Int F1910
Although their babies had undergone scans while in
the neonatal unit, several parents said that they were
quite unprepared for the possibility of being given an ab-
normal result at the scanning visit around term when
US and MRI scans were carried out:
‘Was very worried about the results when the scans
were being done – hadn’t really thought before the
scanning day that may have been given bad news.’
Q2 F7536
‘I did get a little upset at the MRI scan as I didn’t
realise that the tests might find something wrong with
my son. I wasn’t prepared mentally to find out any
bad news.’ Q2 M3321
The same mother reiterated the point later when her
child had reached the age of 2 years:
‘I wasn’t aware what they were looking for with the
scan… I wasn’t prepared for this.’ Q4 M3321
I do think though at the time, we didn’t really prepare
ourselves for how we would feel when we got the
results… We thought about being helpful, you know
the good intention of the project, but I don’t think
we’d really thought through how it was going to affect
us, in terms of how are we going to then deal with
whatever we’re told.’ Y1 Int M2345
The randomisation process
The second key theme focusses on issues relating to ac-
ceptance of the randomisation process, and whether or
not parents appreciated what randomisation meant for
them and their baby.
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Accepting the process
Most parents understood the structure of the trial as
described to them and recognised the difference
between their wishes and what the study design re-
quired. Parents who referred to randomisation gener-
ally apprehended that there was an equal chance of
them being given the MRI or US result and why ran-
domisation was undertaken:
‘We did it hoping to get the MRI result, but we knew
there was a 50:50 chance.’ Yr 2 Int F4845
‘Would have liked MRI result but understand
randomisation process.’ Q2 M5977
‘Yes, it was the ultrasound and not the other one, the
MRI. I think we probably would have preferred the
MRI because we thought it would be more in detail
and more, but we knew it was a totally at random
thing.’ Yr1 Int M3239
While most had accepted the notion of randomisa-
tion, at the same time some acknowledged they would
have preferred to be in the MRI arm of the trial:
‘I would love to know the results of the MRI scan! I
realise, however, that this would negate the purpose of
the study!’ Q2 M1358
However, a few parents ‘would have liked both results’
and on the scanning day they were not prepared for only
one result, though they had been told that at the 2-year
follow-up they would be given the result of the ‘other’
scan:
‘Would have liked result of “other” scan – didn’t
realise wouldn’t get both results.’ Q2 M5301
The qualitative data did show that a few parents
had not understood what was implicit in the ran-
domisation process and that this was integral to the
trial:
‘The selection on which result is get is unfair.’
Q4 M2675
‘I didn’t understand why the results were split
between MRI and ultrasound. I would have liked both
results.’ Q2 F4362
Some parents felt mixed about having the results
and the role of the randomisation process which may
have meant only having some of the information
available:
‘We were very upset for a few weeks following
the scan and results. We found it difficult to
come to terms with the possibility of
problems down the line.’ Q2 M1017
(MRI result received)
‘It was reassuring that the scan did not pick up
any problems, but as it is not conclusive, it is
hard to fully relax due to the results.’ Q4 M1757
(US result received)
‘I would have liked more information about the type
of outcomes and what it meant/could mean, that is
what could an MRI determine for example, what
empirical evidence is there about imaging and future
cognitive impairment etc.’ Q2 M7427
(MRI result received)
Actual engagement with the study
Within this key theme, two subthemes were identified
that arose from parent’s reflections on what the study
really involved. The first focusses on the ‘practicalities’
of the study processes and the second on ‘care from
responsive staff ’.
Practicalities
This subtheme arises from parents’ comments about
the way in which the study was conducted. There was a
particular focus on practical and logistical issues and
the ways in which these impacted on their child, them-
selves and the family. Many of the comments related to
the scanning appointment; the care that they and their
babies received, the facilities available and managing
the scanning of twins and triplets on the same day.
While the scans were seen as valuable, the clinical en-
vironment and necessary procedures could be perceived
as uncomfortable and distressing. Having finally taken
their preterm babies home, several parents described
the challenge of bringing them back to a hospital for
the research study so soon after discharge. Some par-
ents had clearly been conflicted on this point and re-
ferred to practical issues such as a lack of space and
facilities for suitable for siblings, being back in hospital
and negative issues relating to feeding and the use of
sedation. Feeling that they were doing the right thing
was moderated by some of the difficulties experienced
at this time:
Appointments that involved twins and triplets were
longer and more tiring:
‘Yes, it was a pretty tough day because it was
a bit full-on, so, I can’t remember which one
of them actually was a bit fractious that day.
But it was a long day.’ Y1 Int F2047-2059
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‘Helpful to have full facilities for baby care. Generally
a long day with twins but easier to do together than
on separate days.’ Q4 M6470-6487
Most parents, though they may have been worried at
the start of the discussion, did not receive abnormal re-
sults and on reflecting back later indicated that they
enjoyed the scanning day and that they had been made
to feel welcome, comfortable and relaxed: ‘You feel sort
of at home here’; ‘Everything was fine today. I’m normally
quite nervous’; ‘We’ve had a good day out’; and ‘it felt like
it was done very well indeed’:
‘I would just like to add that throughout the day we
were well looked after which made us feel at ease
whatever the outcome of the test results were going
to show.’ Yr 1 Int M2753
Many commented positively about the conduct of the
study, particularly what was seen as the later follow-up
of their child’s development, valuing the arrangements
and the way in which they had been ‘looked after’ in the
context of the ‘assessment’ or ‘test’ that was carried out:
‘Thanks for looking after us so well on the assessment
day; this was the first time we has been out all day
and in itself was a great confidence boosting exercise
with the safety net of being in a hospital!’
Q2 M1447-1459
Care from responsive staff
The importance of a responsive and professional re-
search team was recognised and the individualised na-
ture of the care that parents felt they received was
emphasised in the text giving rise to this subtheme cap-
turing parents’ thoughts about the study team carrying
out the trial. They referred to a need to be treated
‘sympathetically and respectfully’ and staff who had
‘consideration and patience with us… bearing with us’:
‘Staff [were] very supportive when I got emotional [at
the scanning appointment].’ Q4 M2663
‘So when we came there the first time [scanning
appointment]… the people who have been with us
have been very sensitive and very, very good, so it’s
been a very good experience for us.’ Yr 2 Int M1804
While most were parents were grateful to the research
nurses and physicians for the way in which the scans
were carried, not all were positive. Critical comments
generally related to what parents saw as a lack of know-
ledge or sensitivity. This particularly related to feeling
their role as a parent was being usurped or negated:
‘The nurses kept taking my daughter off me
[at the scanning appointment], i.e. to undress her, etc.
Being back in the neonatal is difficult enough without
nurses trying to do everything as well.’ Q2 M3262
‘I think it’s crucial that staff make sure parents don’t
feel excluded from their baby’s care. When our baby
had her assessment [scanning] visit, she was taken
away, without our permission, because she started
crying when the doctor was speaking to us. This was
apparently to help us focus, but it resulted in quite
the opposite effect. I was also made to feel in the way
when I attempted to comfort her during her head
scan.’ Q2 M3438
‘One of my baby’s earplugs came off over and over
again… I let them know… Then X [health care
professional] told me to leave the MRI room. …Her
attitude was extremely aggressive, and I felt as if she
was saying I was an idiot who didn’t listen to her.
This made me so upset and angry. I considered
calling off the test. I volunteered to bring my babies to
the test and saw them not handling my babies with
confidence.’ Q2 M1515-1521
Discussion
This paper addresses the need identified by Shilling et al.
[1] to inform clinicians and practitioners what parents
think about participating in trial-based research. The
parts played by altruism and self-interest in ‘deciding to
take part’ in the trial were identified in the analysis and
are evident in the subthemes of ‘benefitting self ’ and
‘benefitting others’. The subtheme ‘being prepared’ high-
lights the key need for participants to have access to
good quality information, to be well informed and pre-
pared for what might be learned as a consequence of the
trial. ‘Actual engagement’ reflects ‘the practicalities’, that
is the realities of participating in the trial for parents
and their needs in terms of sensitive and ‘care from
responsible staff ’.
The themes identified in this study echo some aspects
of other studies in the academic literature have identified
[19, 20]. In a systematic review of studies on consent to
clinical trials with pre-term or sick neonates, the basic
motivations of parents in agreeing to research [20) were
fairly consistent across multiple studies [4]. Points of dif-
ference are likely to be related to study design, timing
and the nature of the research question asked.
In the trial on which this study was based, the inter-
vention involved significant diagnostic and prognostic
information-giving, but did not, as with some clinical
trials, take place in an urgent or emergency context.
Neither did it involve a clinical intervention such as
medication given in a placebo-controlled trial [21, 22],
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though it did involve outcome assessed at 20–24
months’ corrected age. Relatively well preterm babies
and mothers were scanned having been discharged from
hospital [14]. Knowing more about their baby’s condition
and the possibilities for the longer term was perceived as
a particular benefit of participation for parents taking
part in this trial. The prognostic information provided
following the scanning appointment and the longer-term
follow-up were personal drivers for participation and for
some parents contributed to empowerment. The small
babies and the mismatch in size with the MRI equip-
ment, together with the relief experienced when results
were in the normal range underpinned some parents’
views about the trial experience. The painful emotional
responses of some mothers to some of the interactions
with the health professionals on the scanning day may
reflect echoes of their neonatal experience, their con-
tinued vulnerability after their baby had been dis-
charged home and their strong sense of the need to
naturally protect and care for their babies in the clinical
environment [23, 24].
Other researchers have noted that benefits are not
always tangible. Increasing self-esteem, pride in partici-
pation [25] and feeling valued were important to parents
in this study as was also found in non-trial studies [5].
More broadly, the study parents valued the opportunity
to participate and described appreciating being part of
something bigger, in a continuing way [1].
The study adds to the evidence about parents’ ex-
perience of trials. Engaging them in research and pro-
viding sufficient and appropriate information for them
to be well informed, while balancing their information
and emotional needs is not easy and checks need to be
made on their understanding both at the time of the
recruitment and consent processes, and following the
intervention [17]. The demands and expectations
placed on parents need to be thought through. Most
participate willingly, but there is an impact and a po-
tential emotional burden and staff should not under-
estimate parents’ emotional as well as information
needs in trial participation, particularly in bringing
their baby or babies back to the hospital environment.
A challenge for those taking consent is to ensure that
parents understand all aspects of the study and the im-
plications without overloading them with lengthy,
complex information [26]. Ensuring that the randomi-
sation process is understood by all participating par-
ents is critical in avoiding misunderstandings about
this necessary aspect of study design and its implica-
tions for care or treatment [21, 22, 27].
Strengths and limitations
The triangulation of data using the different sources
available in this study, that is parents’ reflection on their
experiences (interviews and questionnaires) and commu-
nication with clinicians (audio-recordings) at the start of
the trial is a strength, as is the number and diversity of
parents involved [1]. The study also captured the views
and experiences of mothers and fathers. As with other
studies on this topic, a limitation may be that parents
could have felt less able to make critical comments
during the early stages of trial data collection due to the
recency of the care that their infants had received. How-
ever, some clearly did feel able to make negative com-
ments about the way in which the study was conducted
as shown in some of their responses to the question-
naires and in the interviews. The time lag between early
parts of study and later interviews and questionnaires
may have affected parental recall; however, similar views
were expressed across the whole period of data collec-
tion. The longer time frame, during which parents may
have become less anxious, allowed them to reflect and
may be considered a further strength.
Implications for practice
The themes identified and parents’ responses suggest
that there is a need for clinicians and practitioners to re-
flect on their practice and the ways in which they give
information and interact with parents during a study.
An inevitable challenge is that what is right for one
family is not necessarily right for another. Recognising
the parental role during studies of preterm infants and
at clinic is critical from the parents’ perspective, as
most will have experienced early separation and the
rollercoaster of feelings common to parents following
preterm birth. The goal of providing individualised care
for each family, even within a trial, in addition to
provision in the broader environment of neonatal and
paediatric care is critical.
Conclusion
The comments and reflections on the trial described in
this paper represent an opportunity to better understand
what trial participation meant to parents, both at the
time and subsequently. The findings provide insights on
the issues that are important for parents and the ways in
which they viewed the trial design, recruitment and re-
search process. Almost all were positive about their ex-
periences and felt that the family had benefitted from
participation. The practical and logistical points raised
confirm the key issues with regard to research con-
ducted on young babies and their parents and their need
for sensitive care and support in the course of a trial.
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